In mouse models of renal adenocarcinoma and melanoma, treatment with lysovirus dlE102 (OAd)-MSCs reduced tumor volume by 50%, which was associated with increased tumor tissue infiltration by TAMs, NK cells and TILs and a reduced proportion of PD-1 + TILs [593]. This evidence concerns the gene PDCD1 and neoplasm.